Aim: Peripheral artery disease (PAD), defined as a decreased ankle brachial index (ABI), is a risk factor for cardiovascular disease; however, few studies have assessed the relationship between a low ABI and cardiovascular risks in Asian populations. We herein examined the relationship between the ABI and the development of cardiovascular disease in a Japanese community. Methods: A total of 2,954 community-dwelling Japanese individuals without prior cardiovascular disease ≥ 40 years of age were followed up for an average of 7.1 years. The subjects' ABIs were categorized into the three groups: low (≤ 0.90), borderline (0.91-0.99) and normal (1.00-1.40). We estimated the relationship between the ABI and cardiovascular risk using a Cox proportional hazards model. 
Introduction
Peripheral artery disease (PAD) of the lower extremities is an atherosclerotic disease that can cause intermittent claudication, limb ischemia, gangrene, amputations and subsequent decrements in the patient's functional capacity and quality of life 1, 2) . In addition, the presence of PAD is an indicator of systemic atherosclerosis in other vascular territories, such as the coronary, carotid and cerebrovascular arteries 3) . Some epidemiological evidence suggests that individuals with PAD are at an increased risk of cardiovascular mortality and morbidity, such as that involving coronary heart disease and brain infarction [4] [5] [6] [7] [8] [9] . The manifestations of PAD are thus attended by significant personal, social and economic burdens, and PAD is increasingly being recognized as a health problem a medical history of CVD and 152 subjects with no data for the ABI. Two subjects with an ABI of ＞1.40 who were considered to have incompressible calcified arteries in the legs 19) were also excluded because the number of subjects was too small to perform a reliable risk estimation. Finally, the remaining 2,954 participants (1,262 men and 1,692 women) were enrolled.
Follow-Up
The subjects were followed up prospectively from the date of undergoing a comprehensive assessment until November 2009 using annual health examinations. The patient's health status was checked yearly by mail or telephone for any subjects who did not undergo the annual examination in a given year or who moved out of the town. A daily monitoring system was also established among the study team, local physicians and the staff of the health and welfare office in the town. When a subject died, an autopsy was performed at the Department of Pathology of Kyushu University.
ABI Measurement
The ABI was measured with the subject in the supine position after at least five minutes of rest using an automatic oscillometric apparatus (BP-203PRE Ⅱ form PWV/ABI; Omron Healthcare, Kyoto, Japan). Four oscillometric cuffs were wrapped on both brachia and ankles. The cuffs were connected to a central unit that contained four pressure control pumps and four pressure sensors to automatically determine the blood pressure on the four limbs. The ABI was defined as the ankle SBP/brachial SBP ratio, for which the higher value of the brachial SBP between the right and left arms was used. Two readings of the ABI were measured as the same time on the right side and left side, and the lower value was used in the present study. We categorized the ABIs into three groups: low (≤ 0.90), borderline (0.91-0.99) and normal (1.00-1.40), according to the guidelines of the ACC Foundation and AHA 16) .
Risk Factor Measurement
Self-administered questionnaires concerning the subject's current use of anti-hypertensive agents, insulin and oral glucose-lowering agents, as well as smoking habits and alcohol intake were checked by trained interviewers at the time of screening. These variables were classified as being either habitual or not. The subjects engaging in sports or other forms of exertion ≥ 3 times a week during their leisure time made up a regular exercise group. Blood pressure was measured three times using an automated sphygmomanometer worldwide.
Screening to identify individuals with asymptomatic PAD is important, not only for preventing complications directly related to PAD, but also inhibiting the development of cardiovascular disease (CVD). However, the findings of clinical examinations (e.g., skin color and temperature, peripheral pulse and bruits) have poor sensitivity for the detection of asymptomatic PAD 10) . The ankle brachial index (ABI), which is calculated as the ratio of the ankle systolic blood pressure (SBP) to the brachial SBP, is a simple, noninvasive and relatively cost-effective measurement for assessing individuals with asymptomatic PAD 11) . Several epidemiological studies have demonstrated that a lower ABI is associated with a higher cardiovascular risk [4] [5] [6] [7] [8] [9] . Meta-analyses of populationbased cohort studies conducted in Western countries have also suggested that individuals with an ABI below 0.90 have a significantly greater risk of coronary heart disease, stroke and cardiovascular death 12, 13) . Recent guidelines from the European Society of Cardiology, European Society of Hypertension, American College of Cardiology Foundation (ACC) and American Heart Association (AHA) recommend estimating the ABI to detect and manage asymptomatic PAD [14] [15] [16] . However, the relationship between the ABI and the incidence of CVD has not been fully addressed in general Asian populations. It is important to determine whether the cut-off values for the ABI used in epidemiological studies conducted in Western populations are applicable to Asian populations. We herein present the findings of a prospective cohort study that investigated the relationship between the ABI and the incidence of CVD in a general Japanese population.
Methods

Study Population
The Hisayama Study is an ongoing prospective cohort study for CVD and its risk factors in the town of Hisayama, a suburb of the Fukuoka metropolitan area on Kyushu Island, Japan. The population of the town is approximately 8,000, and full community surveys of the residents have been repeated since 1961 17) . In 2002 and 2003, a screening survey for the present study was performed. The detailed description of this survey has been published previously 18) . Briefly, a total of 3,328 residents 40 years of age or older (77.6% of the total population of this age group) participated in the examination and underwent a comprehensive assessment. We excluded 30 subjects who did not consent to participate in the study, 190 subjects who had
Statistical Analysis
We analyzed the linear trends in the mean values and frequencies of the risk factors across the ABI groups using a linear regression analysis and logistic regression analysis, respectively. The event-free survival rates for CVD based on the ABI group were calculated according to the Kaplan-Meier method and compared using a log-rank test. We calculated the incidence of CVD using the person-year method. The hazard ratios (HRs) with 95% confidential intervals (CIs) of cardiovascular events according to the ABI were estimated using a Cox proportional hazards model. The SAS software package (SAS Institute, Cary, NC) was used to perform all statistical analyses. Two-sided p values of ＜0.05 were considered to be significant in all analyses.
Ethical Considerations
This study was conducted with the approval of the Kyushu University Institutional Review Board for Clinical Research. Written informed consent was obtained from all participants.
Results
The baseline characteristics of the study population according to the ABI are shown in Table 1 . The prevalence of low, borderline and normal ABI values were 1.4% (n = 40), 7.3% (n = 216) and 91.3% (n = 2,698), respectively. The subjects with a low ABI were significantly older than those with borderline or normal ABI values. The mean SBP and frequency of diabetes were significantly increased among the subjects with a low ABI.
During the average 7.1-year follow-up period, 134 subjects experienced cardiovascular events, including 85 stroke events and 54 coronary heart disease events. The event-free survival rates for CVD according to the ABI are shown in Fig. 1A . The cardiovascular event-free survival rates across the ABI values were significantly different (log-rank p＜0.001). The subjects with a low ABI had a 5.41-fold (95% CI: 2.64-11.08) higher risk of cardiovascular events compared to those with a normal ABI, whereas there was no evidence of any differences between the subjects with borderline and normal ABI values (p = 0.51) ( Table 2) . This relationship remained substantially unchanged after adjusting for age and sex (HR 2.90 [95% CI: 1.39-6.05]) as well as potential confounding factors, namely, age, sex, systolic blood pressure, anti-hypertensive agents, diabetes, serum total cholesterol, serum HDL cholesterol, obesity, smoking habits, alcohol intake and regular exercise (HR 2.40 [95% CI: 1.14-with the subject in the sitting position after at least five minutes of rest. The mean of three readings was used in this study. Hypertension was defined as a blood pressure of ≥ 140/90 mmHg and/or the current use of anti-hypertensive agents. The plasma glucose levels were measured according to the glucose oxidase method. Diabetes was defined as a fasting plasma glucose level of ≥ 7.0 mmol/L (126 mg/dL), two-hour post-loaded or casual glucose level of ≥ 11.1 mmol/L (200 mg/dL) and/or the current use of insulin or oral glucose-lowering agents. The serum total and highdensity lipoprotein (HDL) cholesterol concentrations were determined enzymatically. Body height and weight were measured with the subject in light clothing without shoes, and the body mass index (BMI) was calculated as body weight/body height 2 (kg/m 2 ). Obesity was defined as a BMI of ≥ 25.0 kg/m 2 . All clinical examinations and blood tests were conducted on the same day as the ABI measurements.
Definition of Cardiovascular Disease
The main outcomes of this study were first-ever events of CVD and its subtypes (coronary heart disease, ischemic stroke and hemorrhagic stroke). Coronary heart disease was defined as acute myocardial infarction, silent myocardial infarction, sudden cardiac death within one hour after the onset of acute illness or the use of coronary interventions (coronary artery bypass surgery and angioplasty). Acute myocardial infarction was diagnosed when a subject met at least two of the following criteria: (1) typical symptoms, including prolonged severe anterior chest pain, (2) abnormally high levels of cardiac enzymes confirmed more than twice, (3) evolving diagnostic electrocardiographic changes and (4) morphological changes, including local asynergy of the cardiac wall motion on electrocardiography, persistent perfusion defects on cardiac scintigraphy or myocardial necrosis and/or the presence of scars measuring 1 cm or longer accompanied by coronary atherosclerosis at autopsy.
Silent myocardial infarction was defined as myocardial scarring without any historical indication of clinical symptoms or abnormal changes in cardiac enzymes. Stroke was defined as the sudden onset of nonconvulsive and focal neurological deficits that continued for ＞24 hours and subclassified as either ischemic or hemorrhagic. All cardiovascular events were assessed based on the findings of a physical examination, review of all available clinical data, including medical records and brain imaging, and an autopsy by a panel of study members who remained blind to the information of the ABI values of the subjects. 
Discussion
The present results clearly demonstrated that an ABI of 0.90 or lower is significantly associated with an increased risk of cardiovascular events. This relationship remained significant after adjusting for potential confounding factors. To the best of our knowledge, this is the first study to prospectively investigate the relationship between the ABI and cardiovascular events in a community-based cohort study of a general Asian population.
The ABI has been investigated as a risk factor in several population-based cohort studies, primarily in North America and Europe [4] [5] [6] [7] [8] . Almost all of these studies found that an ABI of ≤ 0.90 is significantly associated with an increased risk of total mortality [4] [5] [6] , cardiovascular mortality 4-6) and incident coronary heart disease 4, 7) . The ABI Collaboration, an individ-
5.06]).
With regard to the subtype of CVD, the eventfree survival rate for coronary heart disease was significantly different across the ABI groups (log-rank p＜ 0.001), whereas that for stroke was not (log-rank p = 0.15) (Fig. 1B, C) . The multivariable-adjusted risk of coronary heart disease was significantly increased (by 4.13-fold; 95% CI: 1.62-10.55) in the subjects with a low ABI compared to that observed in the subjects with a normal ABI, while there was no evidence of a significant relationship between the ABI values and the risk of stroke. Among the stroke subtypes, however, the univariate analysis revealed that those with a low ABI were at an increased risk of ischemic stroke (HR 4.84; 95% CI: 1.50-15.55), although the significance of the relationship disappeared after adjusting for the above-mentioned confounding factors. No clear relationships between the ABI values and hemorrhagic stroke were observed when the borderline and low ABI groups were combined, as the The risk estimates were adjusted for age, sex, systolic blood pressure, anti-hypertensive agents, diabetes, serum total cholesterol, serum high-density lipoprotein cholesterol, obesity, smoking habits, alcohol intake and regular exercise. c The borderline and low groups were combined. low ABI to be a significant risk factor for stroke events 5, 19, 23) . The Atherosclerosis Risk in Communities Study also found that a low ABI is associated with a higher incidence of ischemic stroke after adjusting for age, race, sex and center; however, this significant relationship disappeared after adjusting for other confounding factors 8) . These results are similar to the present findings, although the relationship in the present study did not reach a level of statistical significance and was largely attenuated compared to that observed in previous studies, possibly because lacunar stroke is the dominant type of ischemic stroke in Japan, whereas large-artery atherothrombotic brain infarction is more prevalent in Western countries 24) . Given the etiology of each stroke subtype, the risk of atherothrombotic brain infarction, as well as coronary heart disease, may be expected to increase in subjects with a low ABI because PAD is an atherosclerotic disease of the large arteries. Atherosclerotic changes in cerebral arteries, as well as coronary arteries, may already be advanced among subjects with PAD defined as an ABI of ≤ 0.9, as PAD is attributable to atherosclerotic remodeling of lower extremity peripheral arteries. The risk of atherothrombotic brain infraction may thus be expected to increase in subjects with a low ABI. Largescale studies are therefore required to elucidate the relationship between a low ABI and the risk of stroke subtypes.
Several limitations of the present study should be noted. First, the generalizability of our findings may be limited, as 152 subjects without available ABI data were excluded from the study. Compared to the subjects who were included, the excluded subjects were older (mean age: 81 years for the excluded subjects vs. 60 years for the included subjects) and more likely to have hypertension (73.7% vs. 43.0%) or a history of cardiovascular events (21.5% vs. 4.5%). This bias would lead to underestimation of the relationship between the ABI and cardiovascular risks. Second, only a single ABI measurement was obtained at the baseline examination. This may have caused the misclassification of subjects into the wrong ABI group. Such misclassification, if present, would weaken the relationship found in this study, biasing the results toward the null hypothesis. Third, we were unable to obtain information regarding the subjects' medical treatment during the follow-up period. The lack of this information may have reduced the accuracy of our findings to some extent. In addition, we used an automatic device to measure blood pressure in the four limbs and the oscillometric method instead of the standard doppler method. The standard doppler method is recommended in the ACC/AHA guidelines ual-based meta-analysis of 16 community-dwelling cohorts conducted in Western countries, clearly demonstrated that a lower ABI (≤ 0.90) approximately doubles the risk of total mortality, cardiovascular mortality and major coronary events compared to an ABI of 1.11-1.20, independent of the Framingham risk score 13) . With regard to Asian populations, a significant relationship between the ABI and cardiovascular risks has been found in several hospital-based prospective studies conducted among patients with risk factors such as metabolic syndrome, ischemic heart disease and chronic kidney disease [20] [21] [22] . For example, the China ABI Cohort Study, a hospital-based study of 3,210 Chinese patients with two or more cardiovascular risk factors, showed that the multivariable-adjusted risk of cardiovascular mortality increased significantly (by 2.0 times) in the subjects with an ABI below 0.90 compared to that observed in the subjects with an ABI above 0.90 20) . However, limited studies have addressed this issue in the general Asian population. Our findings suggest that an ABI of ≤ 0.90 is an independent risk factor for the incidence of CVD in a communitybased Asian population.
In the ABI Collaboration 13) , subjects with an ABI from 0.91 to 1.10 and those with a high ABI (＞ 1.40), which may be related to poor arterial compressibility resulting from stiffness and calcification, were at slightly increased absolute risks of total mortality, cardiovascular mortality and major coronary events. These results suggest that subjects with an ABI of 0.91 to 1.10 or greater than 1.40 may have slightly higher risks of these outcomes than those with a normal ABI, although the widely accepted high-risk cut-off value of 0.90 is reasonable 11) . Based on these findings, the ACC/AHA practice guidelines define ABI categories as low ABI (severe and mild to moderate), borderline ABI, normal ABI and high ABI 16) . In the present study, however, we did not find that borderline ABI was related to the risk of cardiovascular events, likely due to the limited statistical power. Likewise, we were unable to address the relationship between an ABI of ＞1.40 and cardiovascular risk, because only two subjects had an ABI of ＞1.40. The relationship between a borderline or high ABI and the risk of cardiovascular events should be addressed in large samples of Asian populations.
When we investigated the subtypes of cardiovascular events, we observed that, after adjusting for confounding factors, a low ABI was significantly related to an increased risk of coronary heart disease events, but not the risk of stroke. Several epidemiological studies conducted in Western countries have shown a Nichisho-Ippan-004). e463-e654 12) Doobay AV, Anand SS: Sensitivity and specificity of the because some devices using oscillometric blood pressure have been found to overestimate the actual ankle blood pressure, especially in subjects with a very low ankle blood pressure 25) . However, the precision of our device has been validated in both Japanese and European populations 26, 27) , and thus, although this limitation may have reduced the precision of the ABI values to some extent, it is unlikely to have altered the findings substantially.
In conclusion, the present findings indicate that, in a general Japanese population, the subjects with an ABI of ≤ 0.90 had an increased risk of cardiovascular events, independent of traditional cardiovascular risk factors. Because the ABI is a noninvasive and userfriendly method for estimating the extent of systemic atherosclerotic disease, it may be applied more broadly in general practice to identify individuals at a high risk of developing CVD.
